Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Clinical trial NCT01260324 · COMPLETED
Trial details
- NCT number
- NCT01260324
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-03-01
- Enrollment
- 21283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.